Apr 2 |
Sutro Biopharma, Inc. (NASDAQ:STRO) Analysts Just Cut Their EPS Forecasts Substantially
|
Apr 2 |
Sutro Biopharma prices $75M underwritten offering
|
Apr 2 |
Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
|
Apr 2 |
Ipsen secures exclusive global rights of Sutro Biopharma's STRO-003 ADC
|
Mar 27 |
Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
|
Mar 26 |
Sutro Biopharma GAAP EPS of -$1.78 beats by $1.31, revenue of $153.73M beats by $101.4M
|
Mar 25 |
Sutro Biopharma, Inc. (STRO) Q4 Earnings and Revenues Surpass Estimates
|
Mar 25 |
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
|
Mar 21 |
Here's Why Sutro Biopharma (STRO) Is a Great 'Buy the Bottom' Stock Now
|
Feb 28 |
Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
|